Stock screenerAll disclosures →
EDGAR →
ROIV
Conviction 100HealthcareScan · Tue, Sep 8, 2026ROIV$41.47+18.72%
ResistanceSupportVol 14Insider sellCongress buyCongress sell2
4
6
7
Vol MA14 9.97M
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
Price41.47
Change+18.72%
Gap+14.50%
Rel volume4.11×
Avg volume8.75M
Avg $ vol320.36M
SMA 2036.20
SMA 5035.43
SMA 20028.59
Price vs 50+17.06%
Price vs 200+45.03%
MA stackbullish
50/200 cross—
Supertrendup · 34.88
RSI (14)73
MACD hist0.15
MACD crossbull · 0d
Stoch %K / %D89 / 48
ADX (14)17
+DI / −DI45 / 16
RSI divergenceBearish
MACD divergenceBearish
ATR %+4.05%
ADR %3.60%
52w high41.47
52w low12.91
From 52w high+0.00%
Above 52w low+221.22%
New 52w highYes
SqueezeOff
Bollinger width17.57%
%B1.33
Donchian pos88.74%
Donchian high42.49
Donchian low33.43
AVWAP (52w high)40.80
vs AVWAP high+1.64%
AVWAP (52w low)25.65
vs AVWAP low+61.67%
OBV trendFlat
Chaikin MF (20)0.10
Today vs 20d4.11×
Avg vol (14d)9.97M
Avg vol (20d)8.75M
Avg $ vol (20d)320.36M
Market cap29.95B
RS 3m (vs SPY)+17.79%
RS 6m (vs SPY)+6.82%
RS line new highNo
Trend template8/8
Technical rank92.8
1 week+19.72%
1 month+14.12%
3 months+45.56%
6 months+40.43%
1 year+220.98%
YTD+89.10%
P/E-99.93
P/B7.08
P/S—
P/FCF-39.49
EPS-0.5400
Div yield—
ROE-7.08%
ROA-5.65%
Debt/Eq0.05
Current16.72
EV/EBITDA-56.53
Gross margin—
Net margin—
Rev growth-71.57%
EPS growth-74.30%
Price target44.44
Target upside7.16%
Analyst ratingBuy
Institutional83.53%
Ent. value28.93B
Revenue1.44M
Net income-189.84M
Gross profit—
Free cash flow-758.56M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out719.27M
Employees721
ListedFri, Oct 1, 2021
Free float371.02M
Float %51.8%
Short interest30.6M
Days to cover5.0d
Short volume55.6%
Squeeze score67 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.45 vs −$0.45
Last surprise0.0% beat
Setup gradeA+
Conviction100 / 100
Pattern quality—
Tech rank92.8 / 100
Group rank96 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance37.89
Support32.65
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in ROIV · 3 recent
Insider activity
SEC Form 4 transactions in ROIV · 3 buys · 7 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Pulik Richard CFO · Common Shares · 2026-08-20 | Tax | 5.75K | $212K | 2026-08-20 | 2026-08-24 |
Venker Eric President & Immunovant CEO · Common Shares · 2026-08-20 | Tax | 13.91K | $512K | 2026-08-20 | 2026-08-24 |
Sukhatme Mayukh President & CIO · Stock Option (Right to Buy) · 2026-08-21 | Exercise | 144.76K | — | 2026-08-21 | 2026-08-21 |
Sukhatme Mayukh President & CIO · Common Shares · 2026-08-21 | Exercise | 144.76K | $557K | 2026-08-21 | 2026-08-21 |
Sukhatme Mayukh President & CIO · Common Shares · 2026-08-21 | Sell | 144.76K | $5.3M | 2026-08-21 | 2026-08-21 |
Sukhatme Mayukh President & CIO · Stock Option (Right to Buy) · 2026-08-20 | Exercise | 17.52K | — | 2026-08-20 | 2026-08-21 |
Sukhatme Mayukh President & CIO · Common Shares · 2026-08-20 | Exercise | 17.52K | $67K | 2026-08-20 | 2026-08-21 |
Sukhatme Mayukh President & CIO · Common Shares · 2026-08-20 | Sell | 17.52K | $653K | 2026-08-20 | 2026-08-21 |
Sukhatme Mayukh President & CIO · Stock Option (Right to Buy) · 2026-08-19 | Exercise | 172.9K | — | 2026-08-19 | 2026-08-21 |
Sukhatme Mayukh President & CIO · Common Shares · 2026-08-19 | Exercise | 172.9K | $666K | 2026-08-19 | 2026-08-21 |
SEC filings
EDGAR filings in ROIV · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.